Chloral hydrate (DSC)

Drug Overview

Chloral hydrate is one of the oldest synthetic medications in the Psychiatry and neurology fields, classified as a Sedative-Hypnotic drug. Discovered in the 1830s, it was widely used for over a century to help patients fall asleep and to calm children before medical procedures. However, due to the development of safer alternatives, it is important to note that commercial production of this medication has been largely discontinued (DSC) in many countries, including the United States.

Today, it is primarily discussed in academic contexts, though it may still be custom-compounded by specialty pharmacies or used in specific international hospital protocols.

Key details regarding this medication include:

• Generic Name: Chloral hydrate (DSC)
• US Brand Names: Somnote®, Aquachloral®, Noctec® (Note: Most commercial brands are now discontinued)
• Route of Administration: Oral (syrup, capsules) and Rectal (suppositories)
• FDA Approval Status: Originally FDA-Approved (Grandfathered), but currently Discontinued (DSC) in the US market for commercial distribution due to safety and toxicity concerns.

What Is It and How Does It Work? (Mechanism of Action)

Chloral hydrate is a central nervous system depressant that slows down brain activity to induce sleep. Interestingly, chloral hydrate itself is a “prodrug.” This means the drug is inactive when swallowed. Once it enters the body, the liver rapidly converts it into an active chemical called trichloroethanol (TCE).

TCE easily crosses into the brain, where it works at the molecular level:

• GABA Receptor Binding: TCE binds to specific proteins in the brain called GABA_A receptors. GABA (gamma-aminobutyric acid) is the brain’s primary “calming” chemical messenger.
• Opening Chloride Channels: By binding to these receptors, TCE keeps the brain’s tiny cellular gates (chloride channels) open longer. This allows negatively charged chloride ions to flood into the nerve cells.
• Slowing Electrical Impulses: The flood of negative ions makes it much harder for the nerve cells to fire electrical signals. As the electrical activity in the brain quiets down, the patient experiences deep relaxation and sleep.

FDA-Approved Clinical Indications

Historically, chloral hydrate was utilized for its rapid onset of action in calming the nervous system.

• Primary Indication: Short-term treatment of insomnia. It was used to help patients fall asleep, usually for brief periods (less than two weeks) to avoid addiction and tolerance.

Primary Psychiatric Indications

• Insomnia: Short-term management of sleep onset difficulties.
• Alcohol Withdrawal (Historical): Occasionally used in the past to prevent severe withdrawal symptoms, though this is no longer a standard of care.

Off-Label / Neurological Indications

• Pediatric Procedural Sedation: Before the rise of modern anesthetics, it was widely used off-label to sedate children prior to non-painful diagnostic imaging (like an MRI or EEG) or dental procedures.
• Post-Operative Restlessness: Used to calm patients experiencing severe agitation after surgery.

Dosage and Administration Protocols

Note: Because this drug is commercially discontinued, the following reflects historical dosing guidelines or protocols for specialized compounded formulations. It must be administered under strict physician supervision.

Important Adjustments and Considerations:

• Hepatic (Liver) and Renal (Kidney) Impairment: Because the liver creates the active drug and the kidneys clear the toxic byproducts, this medication is strictly contraindicated (should not be used) in patients with severe liver or kidney disease.
• Gastric Irritation: The medication is highly irritating to the stomach lining. It must always be taken with plenty of water, milk, or ginger ale to prevent severe nausea.

Clinical Efficacy and Research Results

Because chloral hydrate is largely discontinued, current clinical research (2020-2026) primarily consists of retrospective studies comparing historical pediatric sedation data to modern alternatives like dexmedetomidine or midazolam.

• Pediatric Sedation Efficacy: Retrospective data analyses from international hospital registries show that chloral hydrate achieved successful sedation for non-invasive procedures (like MRIs) in approximately 85% to 90% of pediatric cases.
• Insomnia: Historical sleep studies, reviewed in recent pharmaceutical safety audits, confirm that doses of 500 mg to 1 g reduced sleep latency (the time it takes to fall asleep) by 15 to 30 minutes. Unlike many other sleep aids, it did not severely disrupt REM (dreaming) sleep.
• Reason for Phase-Out: Despite its high efficacy rate (over 80% response rate for sleep induction), modern reviews (2022-2025) emphasize that 10% to 15% of patients experienced significant adverse events, including dangerous drops in oxygen levels during pediatric sedation, which ultimately justified its removal from standard practice.

Safety Profile and Side Effects

Common Side Effects (>10% incidence):

• Severe stomach upset, nausea, and vomiting
• Unpleasant taste and lingering “hangover” feeling the next morning
• Ataxia (loss of coordination and balance)
• Gas and abdominal distension

Serious Adverse Events:

• Cardiac Arrhythmias: The active metabolite (TCE) makes the heart highly sensitive to adrenaline, which can trigger life-threatening irregular heartbeats.
• Respiratory Depression: Taking too much can severely slow down or stop breathing, similar to a barbiturate overdose.
• Physical Dependence and Tolerance: Using the drug for more than two weeks leads to addiction, and stopping it suddenly can cause severe withdrawal seizures.
• Toxicity / Overdose: The toxic dose is very close to the therapeutic dose. Overdose causes extreme drop in body temperature, pinpoint pupils, and coma.

Management Strategies:

Due to the high risk of stomach upset, doses should be diluted in a full glass of liquid. If a patient experiences a rash, irregular heartbeat, or difficulty breathing, the medication must be stopped immediately, and emergency medical services must be called. In an overdose, supportive hospital care is required, focusing on keeping the airway open and maintaining blood pressure.

Research Areas

While chloral hydrate is rarely used in modern clinics, it remains an important molecule in pharmacological research. Modern neurobiology studies use its historical mechanism on GABA receptors as a baseline to develop safer, non-addictive sleep medications. Additionally, researchers study the pharmacogenomics of the liver enzymes that break down chloral hydrate to better understand why some individuals are highly sensitive to sedatives and anesthetics, paving the way for more personalized, highly targeted sleep therapies in the future.

Disclaimer: The research areas discussed regarding chloral hydrate are based on exploratory and historical scientific investigations. These studies are currently theoretical or in early-stage development and are not yet applicable to established clinical practice or routine professional medical use. 

Patient Management and Practical Recommendations

For patients in international settings where this medication may still be prescribed or compounded, strict management is vital.

Pre-treatment Tests Required:

• Electrocardiogram (ECG) to ensure there are no underlying heart rhythm abnormalities.
• Liver Function Tests (LFTs) and Kidney function tests (Basic Metabolic Panel).
• Review of the patient’s airway and breathing history (e.g., checking for sleep apnea).

Precautions During Treatment:

Chloral hydrate interacts dangerously with many other substances. It should never be combined with other central nervous system depressants.

Do’s and Don’ts:

• DO take the medication exactly as prescribed by your doctor, and only for short-term use (less than 14 days).
• DO mix the liquid form in at least half a glass of water, fruit juice, or ginger ale to protect your stomach.
• DO ensure you have a full 8 hours available to sleep before taking this medication.
• DON’T drink any alcohol. Combining alcohol with chloral hydrate creates a highly toxic and potentially fatal reaction (historically known as a “Mickey Finn” or “knockout drops”).
• DON’T drive, operate machinery, or make important decisions the morning after taking this medication, as it causes severe grogginess.
• DON’T abruptly stop taking the medication if you have been on it for over a week; consult your doctor for a safe tapering schedule.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment plan. Never disregard professional medical advice or delay in seeking it because of something you have read here. Note that availability and legal status of certain medications vary globally.